Rights and permissions
About this article
Cite this article
PEG INF-α-2a/ribavirin cost effective for mild-chronic hep C. Pharmacoecon. Outcomes News 495, 4 (2006). https://doi.org/10.2165/00151234-200604950-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200604950-00009